Golimumab and certolizumab pegol for the treatment of hidradenitis suppurativa: a literature review and future perspective

• প্রধান লেখক: Amirhossein Heidari (Author), Yekta Ghane (Author), Nazila Heidari (Author), Seyedayin Hosseini (Author), Azadeh Goodarzi (Author)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: SAGE Publishing, 2024-05-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Hidradenitis suppurativa (HS) is an inflammatory skin condition with an underlying inflammatory process. Due to the limited efficacy of available treatments, HS remains a therapeutic challenge. The safety and efficacy of tumor necrosis factor-α (TNF-α) inhibitors, adalimumab, infliximab, and etanerc...